Results 81 to 90 of about 7,640 (170)

Assessing mpox knowledge, attitude and willingness to accept the mpox vaccine among people living with HIV and men who have sex with men in selected health facilities in Rivers State, Nigeria: a cross-sectional study. [PDF]

BMJ Public Health
Onyeaghala C, Ogbonna VI, Ugboma IP, Oruh N.   +3 more
europepmc   +1 more source

Mpox-HIV co-infection in a low-incidence setting: epidemiological insights from Qinghai, China. [PDF]

Front Public Health
Kuang J, Shi Y, Dong S, Li X, Cao H, Liang D, Tang Z, Guo F, Fan N, Guo P, Zhao P, Xu L, Li W.   +12 more
europepmc   +1 more source

A rapid evaluation of the preparedness of Ethiopia's disease surveillance system for Mpox outbreak: a cross-sectional study of perspectives from professionals across various levels. [PDF]

Trop Med Health
Zewdie GA, Gulilat H, Abdi KL, Teshome F, Biru G, Nemomssa HD, Malik T, Eshete MT, Woldie M, Zeynudin A, Gebryu AT, Gidi NW, Boltena MT, Kong J.   +13 more
europepmc   +1 more source

MPox Skin Lesions.

Acta medica Indonesiana
Mpox is caused by the Monkeypox virus, which belongs to the Orthopoxvirus genus and Poxviridae family. The Monkeypox virus was first identified as a cause of disease in humans in the 1970s in the Democratic Republic of the Congo. Mpox was considered endemic in several African countries.
Robert Sinto, Alvin Johan, Hanny Nilasari, Evy Yunihastuti, Erni J Nelwan   +4 more
openaire   +3 more sources

The need for sustaining mpox vaccination in Africa. [PDF]

Nat Commun
Boum Y, Doshi RH, Ibeneme CU, Nsasiirwe S, Dereje N, Njenge H, Vilajeliu A, Balde T, Ngongo N, Kaseya J, Lewis RF.   +10 more
europepmc   +1 more source

Determinants of knowledge and attitudes toward Mpox among medical students: A cross-sectional study from Kurdistan region of Iraq. [PDF]

PLoS One
Naqid IA, Mosa AA, Hussein NR, Yaseen IH, Naisan KY, Shuker IT, Kadhim SA, Shareef AS, Almohammed MA.   +8 more
europepmc   +1 more source

A Global Health Alert on the Re-Emergence of Mpox a Viral Zoonotic Illness Its Prevention and Management: A Narrative Review. [PDF]

Health Sci Rep
Aqeel MB, Hanif A, Ahmad S, Shah FI, Javed B, Javed B, Iqbal S.   +6 more
europepmc   +1 more source

Patient with longstanding mpox keratitis successfully treated with topical Cidofovir 0.5% eye drops: a case report. [PDF]

BMC Ophthalmol
Otiti-Sengeri J, Mugisha D, Ngoma DB, Lusobya RC, Atukunda I, Colebunders R.   +5 more
europepmc   +1 more source

Trends of Pathogenicity and Potential Risk Evaluation of Central African Mpox Variant to Cause Global Public Health Emergency: A Cross-Sectional Analysis. [PDF]

Health Sci Rep
Rahman MA, Kozlowich C, Katulka N, Thomas MR, Shanjana Y, Islam MR.   +5 more
europepmc   +1 more source

Plant-based production and characterization of monoclonal antibodies targeting extracellular enveloped proteins of the Mpox Virus. [PDF]

Biotechnol Rep (Amst)
Jirananon K, Shanmugaraj B, Manopwisedjaroen S, Thitithanyanont A, Teengam P, Phoolcharoen W.   +5 more
europepmc   +1 more source